Hematology

Humanigen Struggles Amidst Failed Reverse Merger, Faces Looming Bankruptcy
SG Tylor
Three years ago, Humanigen was on a promising trajectory with a COVID-19 therapy in advanced testing and shares valued at ...
Three years ago, Humanigen was on a promising trajectory with a COVID-19 therapy in advanced testing and shares valued at ...